Compare BRID & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRID | BTMD |
|---|---|---|
| Founded | 1932 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.0M | 72.7M |
| IPO Year | 1995 | 2021 |
| Metric | BRID | BTMD |
|---|---|---|
| Price | $7.90 | $2.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 1.7K | ★ 183.1K |
| Earning Date | 06-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | $174,257,000.00 | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $34.50 |
| Revenue Growth | ★ 4.21 | N/A |
| 52 Week Low | $7.00 | $1.27 |
| 52 Week High | $8.73 | $4.75 |
| Indicator | BRID | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 48.02 |
| Support Level | $7.31 | $1.35 |
| Resistance Level | $8.07 | $2.79 |
| Average True Range (ATR) | 0.20 | 0.15 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 64.74 | 35.23 |
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The two business segments are: the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches, among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, mass merchandise, and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.